在急诊室治疗传染性腹的多学科方法
Muhammad Kalim Ullah1, Fahad Dayam2, Aamir Ahmed3
1General Medicine, Rehman Medical Institute, Peshawar, PAK.
Cureus
|September 26, 2024
概括
多学科方法 (MDA) 显著改善了急诊部 (ED) 的传染性腹管理,导致更好的患者结果和更少的并发症. 这一策略提高了感染性腹患者的治疗效果和症状缓解.
科学领域:
- 公共卫生 公共卫生
- 传染性疾病 传染性疾病
- 紧急医疗 紧急医疗
背景情况:
- 传染性腹是一个全球性的公共卫生问题,特别是在急诊室 (EDs),需要迅速有效的干预.
- 这项研究解决了对高急性设置中传染性腹的优化管理策略的关键需求.
研究的目的:
- 评估多学科方法 (MDA) 在急诊室 (ED) 管理传染性腹的有效性.
- 评估MDA对患者结果,治疗有效性和并发症率的影响.
主要方法:
- 一项前性队列研究,涉及650名被诊断患有传染性腹的成人患者,在巴基斯坦佩沙瓦的Lady Reading医院ED.
- 数据收集包括人口统计,临床表现,诊断结果,治疗和使用标准化表格的结果.
- 统计分析采用描述统计和后勤回归来确定影响治疗成功和并发症的因素.
主要成果:
- 大多数患者年龄在30-39岁之间,性别分布几乎平等.
- 细菌病原体是最常见的原因 (310例),其次是病毒 (160) 和寄生虫 (110) 感染.
- 观察到高治疗效率 (91.08%) 和症状缓解 (90.77%). 像败血症这样的并发症发生在5.69%的患者中.
- 后勤回归确定了更长的症状持续时间和特定的抗生素作为治疗成功的预测因素.
- 晚年和严重脱水与增加的并发症风险有关.
结论:
- 多学科方法 (MDA) 显著提高了急诊室 (ED) 传染性腹管理中的患者结果.
- 实施MDA导致治疗效率提高,并发症率降低.
- 这种方法为优化在紧急情况下的传染性腹护理提供了有价值的策略.
相关概念视频
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
110
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
110
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
2
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
2
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
323
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
323
Acute Pyelonephritis II: Diagnostic Studies and Management
2
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
2
Inflammatory Bowel Disease IV: Pharmacological Management
118
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
118
Drugs for Treatment of Diarrhea-Predominant IBS
152
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
152


